Indian Energy Exchange and Apollo Pipes have announced their respective record dates for the issuance of bonus shares for eligible shareholders
These injections will help control high blood sugar in adult and pediatric patients with type-1 diabetes and adults with type-2
India has one of the largest populations of children and adolescents living with Type 1 diabetes in the world with an estimated 1 million patients in this age group
In a Q&A, Shreehas Tambe talks about the road ahead for the firm's biosimilars business and how its alliance with Serum is projected to pan out
The technical analyst from Religare Broking also recommends to accumulate United Spirits. Check out the range below
Revenue growth was primarily driven by good performance of its research services and biosimilars business segments
Stock market LIVE: The broader markets also ended with notable losses as profit-taking continued for the third straight trading session, amid valuation and inflation concerns
The USFDA had approved biosimilar Insulin Glargine-yfgn injection (Semglee) as the first interchangeable biosimilar product in July this year
State-run PSU banks and telecom stocks are likely to be in focus along with a slew of mid- and small-cap companies that shall announce their September earnings today
According to a company statement, the Deanstone Trust, which was mentioned as part of a leak of offshore tax haven files called the 'Pandora Papers,' was set up for philanthropic endeavours
Kiran Mazumdar-Shaw, executive chairperson of Biocon denied any impropriety
Kunal Kashyap's Sebi order was also linked to Biocon. It was related to a 2018 announcement about Biocon's global collaboration with Sandoz
State-owned power giant NTPC has bagged 1.9 GW solar projects in CPSU Scheme-II tender
Work on mRNA platform, antibodies for dengue, HIV in the plan
On the weekly basis, the benchmark indices gained, thus taking their winning run to the fourth straight week
Hero MotoCorp on Thursday said it will increase the price of its entire model range by up to Rs 3,000 from September 20
Biocon Biologics, a subsidiary of Biocon, on Thursday said it will offer around 15 per cent stake to Serum Institute Life Sciences at a post-money valuation of about $4.9 billion
Sebi had directed Allegro Capital and its owner Kunal Kashyap to disgorge Rs 25 lakh for allegedly dealing in shares of Biocon while in possession of price sensitive information.
Business Standard brings to you the top headlines on Friday
Semglee may now be substituted for Sanofi's Lantus by a pharmacist in the US